title: Recording the corpus cavernosum electromyogram: principles and problems.
abstract: OBJECTIVE
  To apply digital signal acquisition and analyzing techniques to the collection and interpretation of electromyographic data of the cavernous body.
  
  
  METHODS
  Electromyographic recordings were performed in the cavernous bodies of anesthetized, spontaneously breathing dogs under resting conditions and after intracavernous pharmacostimulation with norepinephrine, angiotensin II, phentolamine/papaverine, diethylether and T61.
  
  
  RESULTS
  Resting corpus cavernosum activity was ill-coordinated and provided little information. Signal energy was confined largely to the range below 20 Hz. Pharmacostimulation with norepinephrine or angiotensin increased frequency and amplitude of the potential transients and decreased the random components. Administration of a combination of phentolamine and papaverine made the signals very regular and increased periodicity. Blockade of electrical membrane events with diethylether removed all signal components except for electrical and biological noise.
  
  
  CONCLUSIONS
  Our findings indicate that electromyograms from the corpus cavernosum can be recorded even under adverse conditions. Signal properties, however, are such that the application of computer-aided data processing and analysis to the evaluation of these myograms is imperative.
authors.affiliation: Department of Urology, Klinikum Mannheim, University of Heidelberg, Germany.
authors.forename: J R
authors.initials: JR
authors.lastname: Scheepe
authors.forename: K P
authors.initials: KP
authors.lastname: Jünemann
authors.forename: C P
authors.initials: CP
authors.lastname: Bührle
authors.forename: P
authors.initials: P
authors.lastname: Schmidt
authors.forename: G
authors.initials: G
authors.lastname: Wipfler
authors.forename: B
authors.initials: B
authors.lastname: Berle
authors.forename: P
authors.initials: P
authors.lastname: Alken
mesh_terms: D000577:Amides / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D004285:Dogs; D004338:Drug Combinations; D004576:Electromyography / Q000379:methods*; D004986:Ether / Q000494:pharmacology; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010410:Penile Erection / Q000187:drug effects / Q000502:physiology*; D010413:Penis / Q000502:physiology*; D010646:Phentolamine / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012815:Signal Processing, Computer-Assisted; D013748:Tetracaine / Q000494:pharmacology
chemical_list: D000577:Amides; D004338:Drug Combinations; D000644:Quaternary Ammonium Compounds; D013748:Tetracaine; D004986:Ether; D000804:Angiotensin II; C015591:T 61; D010208:Papaverine; D009638:Norepinephrine; D010646:Phentolamine